Related Experiment Video
Updated: Feb 12, 2026

Synthesis of Graphene-Hydroxyapatite Nanocomposites for Potential Use in Bone Tissue Engineering
Published on: July 27, 2022
Triple-component nanocomposite films prepared using a casting method: Its potential in drug delivery
Sadia Gilani1, Sadullah Mir2, Momina Masood1
1Department of Pharmacy, COMSATS Institute of Information Technology, Abbottabad, Pakistan.
This study developed chitosan-polyethylene glycol (PEG) nanocomposite films for drug delivery. Higher PEG concentrations enhanced piroxicam-β-cyclodextrin release and skin permeation, showing potential for localized delivery.
Area of Science:
- Materials Science
- Nanotechnology
- Pharmaceutical Sciences
Background:
- Chitosan-based nanocomposites are promising for drug delivery.
- Polyethylene glycol (PEG) can modify nanocomposite properties.
- Piroxicam-β-cyclodextrin is a model drug for anti-inflammatory applications.
Purpose of the Study:
- To fabricate chitosan-PEG nanocomposite films.
- To evaluate their potential for drug delivery.
- To investigate the effect of PEG molecular weight on film characteristics.
Main Methods:
- Casting/solvent evaporation method for film preparation.
- Characterization using XRD, SEM, TGA, and FTIR.
- In vitro drug release, swelling, water content, and anti-inflammatory activity tests.
- Ex vivo permeation studies using Franz diffusion cell.
Main Results:
- Film properties and drug release were sensitive to pH and ionic strength.
- Increased PEG concentration correlated with higher swelling, water content, and drug permeation.
- Formulation F10 (75% PEG) exhibited optimal swelling, permeation, and in vitro release.
- Significant anti-inflammatory effect was observed with the developed films.
Conclusions:
- Chitosan-PEG nanocomposite film composition significantly impacts drug release.
- PEG molecular weight influences swelling, drug release, and permeation rates.
- These developed films show promise for localized transdermal drug delivery.
Related Concept Videos
Drug Binding to Blood Components
HSA is the most abundant plasma protein and is vital in drug binding. It contains distinct drug-binding sites, with different drugs exhibiting affinity for specific sites. There are three main drug-binding domains for HSA: sites I, II, and III. These domains are...
Vector Algebra: Method of Components
In many applications, the magnitudes and directions of...
Drug Delivery: Overview
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
Drug Delivery: Enteral Route
Drug Delivery: Parenteral Route
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
Transdermal Drug Delivery Systems

